RUBAM

E: info@rubam.net
P: +34 934 006 100, ext 1215
  • Home
  • Group Members
  • Research
    • Overview
    • Chemistry and Biology of Sphingolipids
    • Targeted Protein Degradation
    • Chemical Ecology
    • Lipidomics: Development of analytical tools and methods
    • Thesis Dissertations
  • Projects and Research Agreements
    • Currently Active Projects
    • Recently Finished Projects
  • Publications
  • Collaborations
  • Chemical Probes
  • Job Opportunities
  • Contact Us

Research >> Chemistry and Biology of Sphingolipids

Sphingolipids (SLs) regulate signal transduction pathways involved in several biological processes. Dysregulation of SL metabolism leads to the outburst and progression of diseases, from rare syndromes to disorders of high socio-economic impact. Several enzymes of SL metabolism have been validated as therapeutics targets, including ceramide synthases (CerS), dihydroceramide desaturase (Des1), ceramidases (CDases) and sphingosine-1-phosphate (S1P) lyase (Sgpl1). Therefore, the discovery of compounds able to modulate these enzyme activities is of pharmacologic relevance. Such compounds may arise from library screening, which requires the availability of high throughput screening (HTS) methods, currently very scarce. On the other hand, knowing the molecular mechanisms involved in SL functions may lead to the identification of novel therapeutic targets. This line encompasses the chemical synthesis of small molecules and the study of their role on/as:

1) Cell fate, with special attention to apoptosis, autophagy and cytoplasmic vacuolation processes. Identification of molecular targets involved in the activity of Jaspine B at inducing cytoplasmic vacuolation and methuosis. Biological models include several types of cancer.

Autophagosomes produced in glioblastoma U87MG cells treated with a dihydroceramide desaturase inhibitor
Formation of cytoplasmic vacuoles in gastric cancer HGC27 cells upon incubation with a sphingolipid analog

2) Pharmacological chaperones of mutated enzymes in rare diseases. Biological models include Niemann-Pick, Gaucher and Farber disease.

Labelling of lysosomal acid ceramidase (AC) with a fluorescent activity based probe (ABP) in Farber cells corrected with active AC.

3) Cell membrane composition. Biological and biophysical models for the study of infective and cell-cell communication processes.

The physical properties and the curvature of the cell membrane can be altered from an “infective” to a “non-infective” architecture by variation of the sphingolipid composition. This composition can be modulated by inhibitors of the sphingolipid biosynthesis. The image shows a mechanistic rationale to explain how a membrane enriched in dihydrosphingomyelin, by effect of the enzyme inhibitor GT11pyr, prevents the infection by HIV.

4) Inhibitors of sphingolipid metabolism with biomedical applications. Structural modifications of natural sphingolipids to design inhibitors or modulators of sphingolipid metabolism.

Structure-activity relationships (SAR) in sphingolipids

5) Sphingolipid probes as tools for trafficking and analytical applications. The bioactive molecules of interest are either rationally designed, according to the target protein, or obtained as targeted combinatorial libraries. In this case, the development of high throughput screening (HTS) procedures is required. A general approach is shown below:

Design of a HTS assay for a SL metabolising enzyme. A solid supported quencher is designed to selectively react with an azidetagged SL product of the reaction catalyzed by the target enzyme. A fluorescence readout system, based on Cu-free click chemistry, is used.

Our current interests in this area are addressed at the following targets:

1. Set-up of HTS methods based on novel self-immolative substrates for Sgpl1 (luminogenic S1P analogs) and alkaline ceramidases ACER1 and ACER2 (fluorogenic ceramide analogs).
2. Development of Sgpl1 activity-based probes.
3. To explore the performance of proteolysis targeting chimeras (PROTACS) as modulators of sphingolipid metabolism.

Contact Us

CID-CSIC
Carrer de Jordi Girona 18-26
08034 Barcelona
+34 934 006 100, ext 1215
info@rubam.net

Quick Access

  • Group Members.
  • Research.
  • Currently Active Projects.
  • Recently Finished Projects.
  • Publications.
  • Collaborations.
  • Chemical Probes.
  • Job Opportunities.
  • Contact Us.

Copyright © 2023 · Legal Disclaimer · Privacy Policy· Cookies Policy

Contact Us · +34 934 006 100, ext 1215 · info@rubam.net

Web Design: DespachoTres.com

Web Segura - Comodo SSL Certificate

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible.

La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudarnos a comprender qué secciones de la web encuentras más interesantes y útiles.

Más información en nuestra política de privacidad.

Cookies técnicas necesarias

Las cookies técnicas necesarias tienen que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies. Básicamente, esta web no funcionará bien si no están activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad imprescindibles.
  • Saber si ya has aprobado/rechazado las cookies.
Cookies de Terceros

La web rubam.net utiliza las siguientes cookies:

  • Google Analytics: se utiliza para enviar datos a Google Analytics sobre el dispositivo del visitante y su comportamiento en el sitio web de rubam.net, de forma anónima. Más información: https://policies.google.com/privacy

¡Primero habilite las cookies estrictamente necesarias para que podamos guardar sus preferencias!

Política de Cookies

Más información en nuestra política de cookies.